mRNA Breakthroughs
A Harvard connection led to the founding of Moderna, which raised $2.5 billion before its IPO in 2018, all while maintaining a shroud of secrecy. Meanwhile, a husband-wife team in Germany pursued mRNA technology with an academic focus, publishing extensively and attracting talent like Catalin. Both companies would soon find themselves at the forefront of a global health crisis, changing the landscape of vaccine development forever.In this clip
From this podcast
Prognosis: Misconception
Breakthrough: Unlikely Heroes
Related Questions
Can vaccine development be accelerated as discussed in the episode Biotech Revolution with Software Engineering Daily and the clip Innovative Go-to-Markets, in the context of the episode 510: Rob Reid | Why the Future is a Good Kind of Scary and the clip Printing Vaccines?
Can vaccine development be accelerated as discussed in the episode Biotech Revolution with Software Engineering Daily and the clip Innovative Go-to-Markets, in the context of the episode 510: Rob Reid | Why the Future is a Good Kind of Scary?
Can vaccine development be accelerated as discussed in the episode Biotech Revolution with Software Engineering Daily and the clip Innovative Go-to-Markets, in the context of the episode 510: Rob Reid | Why the Future is a Good Kind of Scary and the clip Printing Vaccines?